SEC Form 4 · accession 0001209191-18-064210
Audentes Therapeutics, Inc. · BOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis G Lange
Director
Period of report
Dec 24, 2018
Accepted (ET)
Dec 27, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 24, 2018 | S | 20,000 | $18.6717 | D | 325,799 | D | |
| Common StockF3,F4 | Dec 24, 2018 | S | 1,000 | $18.701 | D | 17,678 | I | By Amygdala Lange Trust |
| Common StockF3,F5 | Dec 24, 2018 | S | 1,000 | $18.713 | D | 558 | I | By Lange Minor's Trust |
| Common StockF6,F7 | Dec 24, 2018 | S | 10,000 | $18.4951 | D | 32,343 | I | By Asset Management Ventures Fund, L.P. |
| Common StockF8 | holding | — | — | — | 3,555 | I | By Adrienne M. MacMillan Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Represents the weighted average sale price. The lowest price at which shares were sold was $18.28 and the highest price at which shares were sold was $19.09. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (6) to this Form 4.
- F3Represents the weighted average sale price. The lowest price at which shares were sold was $18.40 and the highest price at which shares were sold was $18.98.
- F4The reporting person's spouse is the trustee of the Amygdala Lange Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- F5The reporting person's spouse is the trustee of the Lange Minor's Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- F6Represents the weighted average sale price. The lowest price at which shares were sold was $18.23 and the highest price at which shares were sold was $18.64.
- F7The reporting person is a general partner of Asset Management Ventures Fund, L.P. ("AMVF L.L.P."), and has shared voting and dispositive power over the shares held by AMVF L.L.P. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F8The reporting person's spouse is the trustee of the Adrienne M. MacMillan Revocable Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.